Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd.

Biotechnology • Healthcare • Ashburn, VA, United States • QNRX (NCM)

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

703 980 4182 42127 Pleasant Forest Court, Ashburn, VA 20148-7349, United States

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Quoin Pharmaceuticals stock soars after achieving target rapamycin loadings - Investing.com
Investing.com • Nov 11
Quoin (NASDAQ: QNRX) to make clinical/stability batches after 4% and 5% rapamycin loads - Stock Titan
Stock Titan • Nov 11
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million - GlobeNewswire
GlobeNewswire • Oct 10
Is Quoin Pharmaceuticals Stock Poised For A Rebound? - StocksToTrade
StocksToTrade • Nov 11
Quoin Pharmaceuticals (QNRX) Stock Skyrockets 140% on $104.5M Private Placement Deal - CoinCentral
CoinCentral • Oct 10

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Quoin Pharmaceuticals, Ltd. had layoffs?
No layoff events have been recorded for Quoin Pharmaceuticals, Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Quoin Pharmaceuticals, Ltd. have?
Quoin Pharmaceuticals, Ltd. has approximately 3 employees.
What industry is Quoin Pharmaceuticals, Ltd. in?
Quoin Pharmaceuticals, Ltd. operates in the Biotechnology industry, within the Healthcare sector.
Is Quoin Pharmaceuticals, Ltd. a publicly traded company?
Yes, Quoin Pharmaceuticals, Ltd. is publicly traded under the ticker symbol QNRX on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is Quoin Pharmaceuticals, Ltd. headquartered?
Quoin Pharmaceuticals, Ltd. is headquartered in Ashburn, VA, United States at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.